Central Nervous System

·         06A027 – Skin Vaccination for Alzheimer's Disease

·         05B105 - Identification of drugs for efficacy to treat stroke at delayed timepoints

·         05A046 - Novel method of treatment for stroke using sigma receptor agonists

·         04B077 - T-Cell Transfer Offers Novel Treatment of Alzheimer’s Disease

·         03B082 - Modulation of microglia inflammation by nicotinic medications - therapeutics for neuro-inflammation (neurodegenerative diseases)

·         03B072 - A method for accurately measuring anti-amyloid beta antibody in samples containing amyloid beta peptide (neurodegenerative diseases)

·         03B063 - Cholinergic modulation of microglial activation by alpha7 nicotinic receptors (neurodegenerative diseases)

·         03A009 - An E2F1 RNA inhibitor to prevent apoptosis (stroke)

·         01A004 - Proliferated Cell Lines and Uses Thereof

·         98B046 - Transgenic mouse with ACT gene (neurodegenerative diseases)

·         96B024 - The APP+PS1 transgenic mouse: a model for testing drugs to treat Alzheimer's Disease

Main menu 8